MYOCARDIAL PROTECTION BY NHE-1 INHIBITION
NHE-1 抑制对心肌的保护
基本信息
- 批准号:6662580
- 负责人:
- 金额:$ 27.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-30 至 2006-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
The current proposal is for studies on the mechanisms of myocardial protection associated with
inhibition of the sarcolemmal Na+-H+ exchanger isoform-1 (NHE-1). Studies are conducted in a
porcine model of whole-body ischemia induced by ventricular fibrillation (VF) in which resuscitation is either attempted using conventional closed-chest resuscitation or simulated using peripheral cardiopulmonary bypass, according to four specific aims designed to study 1) the mechanisms by which NHE-1 inhibition ameliorates ischemic contracture during resuscitation from VF, 2) the mechanisms by which post-resuscitation ventricular ectopic activity is reduced after NHE-1inhibition, 3) the late post-resuscitation effects of NHE-1 inhibition on cardiovascular and neurological function, and 4) the effects of NHE-1 inhibition when instituted before the onset of VF on subsequent resuscitation and survival.
The mechanisms of ischemic contracture are investigated by measuring myocardial blood flow
(fluorescent microspheres) and oxidative injury (isoprostane levels) in a closed-chest resuscitation model and by measuring myocardial Na+ and high-energy nucleotides under conditions of controlled coronary blood flow using cardiopulmonary bypass. The mechanisms of
post-resuscitation ectopic activity are investigated by recording monophasic action potentials in
relation to NHE-1 inhibition, Na+-Ca2+ exchanger inhibition, and sarcolemmal K+ATP channel
blockade. The late post-resuscitation outcome is assess by using implantable sensors measuring blood pressure, the electrocardiogram, temperature, and mobility over a period of 7 days post-resuscitation. Finally, the effects of pretreatment with NHE-1 inhibition are compared with those when treatment is started during the resuscitation effort. Interventions that can increase outcome after onset of VF (even by a small fraction) could have a dramatic public health effect by saving thousands of lives.
描述(由申请人提供):
目前的建议是研究与心肌保护有关的机制,
抑制肌膜Na+-H+交换器亚型-1(NHE-1)。 研究是在一个
由心室纤维性颤动(VF)诱导的全身缺血的猪模型,其中使用常规的闭胸复苏尝试复苏或使用外周心肺转流模拟复苏,根据四个特定的目的,设计用于研究1)NHE-1抑制改善VF复苏期间缺血性挛缩的机制,2)NHE-1抑制后复苏后心室异位活动减少的机制,3)NHE-1抑制对心血管和神经功能的复苏后晚期效应,以及4)在VF发作之前开始抑制NHE-1对随后的复苏和存活的影响。
通过测量心肌血流量来研究缺血性挛缩的机制
(荧光微球)和氧化损伤(异前列腺素水平),并通过在使用心肺转流术的受控冠状动脉血流的条件下测量心肌Na+和高能核苷酸。 的机制
复苏后异位活动的研究通过记录单相动作电位,
与NHE-1抑制、Na+-Ca 2+交换抑制和肌膜K+ATP通道的关系
封锁 通过使用植入式传感器测量复苏后7天内的血压、心电图、体温和活动性来评估复苏后晚期结果。 最后,将用NHE-1抑制预处理的效果与在复苏努力期间开始治疗的效果进行比较。 可以增加VF发作后的结果(即使是一小部分)的干预措施可以通过挽救数千人的生命而产生巨大的公共卫生影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raul Jaime Gazmuri其他文献
Raul Jaime Gazmuri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raul Jaime Gazmuri', 18)}}的其他基金
Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival
格列净减轻心脏骤停期间的再灌注损伤,改善复苏后心肌功能和生存率
- 批准号:
10366212 - 财政年份:2022
- 资助金额:
$ 27.3万 - 项目类别:
Attenuation of Reperfusion Injury by Gliflozins During Cardiac Arrest Leading to Improved Post-Resuscitation Myocardial Function and Survival
格列净减轻心脏骤停期间的再灌注损伤,改善复苏后心肌功能和生存率
- 批准号:
10531884 - 财政年份:2022
- 资助金额:
$ 27.3万 - 项目类别:
Cyclophilin-D: A Regulator of Mitochondrial Oxidative Phosphorylation
亲环蛋白-D:线粒体氧化磷酸化的调节剂
- 批准号:
10265322 - 财政年份:2018
- 资助金额:
$ 27.3万 - 项目类别:
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest
心脏骤停复苏期间促红细胞生成素对心肌的影响
- 批准号:
7931837 - 财政年份:2010
- 资助金额:
$ 27.3万 - 项目类别:
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest
心脏骤停复苏期间促红细胞生成素对心肌的影响
- 批准号:
8394593 - 财政年份:2010
- 资助金额:
$ 27.3万 - 项目类别:
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest
心脏骤停复苏期间促红细胞生成素对心肌的影响
- 批准号:
8195595 - 财政年份:2010
- 资助金额:
$ 27.3万 - 项目类别:
Myocardial Effects of Erythropoietin During Resuscitation from Cardiac Arrest
心脏骤停复苏期间促红细胞生成素对心肌的影响
- 批准号:
8262624 - 财政年份:2010
- 资助金额:
$ 27.3万 - 项目类别:
相似海外基金
Gut microbial metabolite- Trimethylamine-N-oxide and endothelial inflammasome signaling in cardiovascular injury
肠道微生物代谢物-三甲胺-N-氧化物和心血管损伤中的内皮炎性体信号传导
- 批准号:
10002639 - 财政年份:2019
- 资助金额:
$ 27.3万 - 项目类别:
Role of P2X7 receptor in angiotensin-II induced hypertension and cardiovascular injury
P2X7受体在血管紧张素II诱导的高血压和心血管损伤中的作用
- 批准号:
386428 - 财政年份:2017
- 资助金额:
$ 27.3万 - 项目类别:
Studentship Programs
Project 2: Cardiovascular Injury Due to Tobacco Use
项目 2:吸烟引起的心血管损伤
- 批准号:
8595393 - 财政年份:2013
- 资助金额:
$ 27.3万 - 项目类别:
Reversibility of Cardiovascular Injury with CPAP Use: Mechanisms Involved
使用 CPAP 治疗心血管损伤的可逆性:涉及的机制
- 批准号:
7787358 - 财政年份:2010
- 资助金额:
$ 27.3万 - 项目类别:
Reversibility of Cardiovascular Injury with CPAP Use: Mechanisms Involved
使用 CPAP 治疗心血管损伤的可逆性:涉及的机制
- 批准号:
8268439 - 财政年份:2010
- 资助金额:
$ 27.3万 - 项目类别:
Reversibility of Cardiovascular Injury with CPAP Use: Mechanisms Involved
使用 CPAP 治疗心血管损伤的可逆性:涉及的机制
- 批准号:
8128513 - 财政年份:2010
- 资助金额:
$ 27.3万 - 项目类别:
Reversibility of Cardiovascular Injury with CPAP Use: Mechanisms Involved
使用 CPAP 治疗心血管损伤的可逆性:涉及的机制
- 批准号:
8471749 - 财政年份:2010
- 资助金额:
$ 27.3万 - 项目类别:
Cardiovascular Injury and Repair Research Facility
心血管损伤与修复研究设施
- 批准号:
7000233 - 财政年份:2009
- 资助金额:
$ 27.3万 - 项目类别: